Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential
Elisabete Fernandes, Dylan Ferreira, Andreia Peixoto, et al.
International Journal of Pharmaceutics (2019) Vol. 570, pp. 118646-118646
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy, Chanakya Nath Kundu
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111285-111285
Open Access | Times Cited: 385
Synthesis of 5-Fluorouracil Cocrystals with Novel Organic Acids as Coformers and Anticancer Evaluation against HCT-116 Colorectal Cell Lines
Farhat Jubeen, Aisha Liaqat, Fiza Amjad, et al.
Crystal Growth & Design (2020) Vol. 20, Iss. 4, pp. 2406-2414
Open Access | Times Cited: 91
Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
Xiangyi Kong, Ran Cheng, Jing Wang, et al.
Nano Today (2020) Vol. 36, pp. 101004-101004
Closed Access | Times Cited: 73
Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
Umme Hani, Riyaz Ali M. Osmani, Sabina Yasmin, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1576-1576
Open Access | Times Cited: 44
Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer
Shenghe Deng, Junnan Gu, Zhenxing Jiang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
Sergio Andrés Torres-Pérez, Cindy Estefani Torres-Pérez, Martha Pedraza‐Escalona, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 53
Glycans as Targets for Drug Delivery in Cancer
Francisca Diniz, Pedro Coelho, Henrique O. Duarte, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 911-911
Open Access | Times Cited: 36
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence
Jonathan Zaslavsky, Pauric Bannigan, Christine Allen
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 2, pp. 241-257
Closed Access | Times Cited: 17
Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines
Rui Freitas, Andreia Peixoto, Eduardo Ferreira, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108144-108144
Open Access | Times Cited: 16
Nanoparticles guided drug delivery and imaging in gastric cancer
Ganji Purnachandra Nagaraju, Gowru Srivani, Begum Dariya, et al.
Seminars in Cancer Biology (2020) Vol. 69, pp. 69-76
Closed Access | Times Cited: 39
Biomembrane‐coated nanosystems as next‐generation delivery systems for the treatment of gastrointestinal cancers
Joana Lopes, Daniela Lopes, Mahzad Motallebi, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Nano drug delivery systems in upper gastrointestinal cancer therapy
Julia Salapa, Allison Bushman, Kevin Lowe, et al.
Nano Convergence (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 37
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
Qingxia Fu, Jiancheng Wang, Liu Hong
Drug Delivery (2020) Vol. 27, Iss. 1, pp. 1535-1543
Open Access | Times Cited: 35
Nanotechnology-based strategies for gastric cancer imaging and treatment
Xianghui Li, Shichao Ai, Xiaofeng Lu, et al.
RSC Advances (2021) Vol. 11, Iss. 56, pp. 35392-35407
Open Access | Times Cited: 27
Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
Yuna Guo, Wenshuang Jia, Jingru Yang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Insights into the Molecular Mechanisms and Nanoparticle-Based Therapies for Gastric Cancer: A review
Smarika Chauhan, Eswar Marcharla, Sneha Hariharan, et al.
Results in Engineering (2025), pp. 104238-104238
Open Access
Docetaxel-loaded pH/ROS dual-responsive nanoparticles for the targeted treatment of gastric cancer
Ju Wu, Kun Du, Ying Bao, et al.
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Closed Access
Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
Elisabete Fernandes, Rui Freitas, Dylan Ferreira, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 861-861
Open Access | Times Cited: 29
Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis
Nora Bloise, Mohammad Okkeh, Elisa Restivo, et al.
Nanomaterials (2021) Vol. 11, Iss. 2, pp. 289-289
Open Access | Times Cited: 25
Molecular targeted treatment and drug delivery system for gastric cancer
Lanxin Jiang, Xiaomin Gong, Wangdi Liao, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 4, pp. 973-986
Closed Access | Times Cited: 25
Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice
Cristiane Monteiro Pinto, Laila Sampaio Horta, Amanda P. Soares, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1021-1021
Open Access | Times Cited: 20
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy
Rui Freitas, Eduardo Ferreira, Andréia Miranda, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 10088-10103
Closed Access | Times Cited: 2
“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy
Ning Ding, Shengjun Xu, Sheng Zheng, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 12, pp. 2816-2830
Open Access | Times Cited: 13
Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer
Li Zhang, Virginia Aragon‐Sanabria, Anusha Aditya, et al.
Advanced Therapeutics (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 9
The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy
Luzhou Xu, Lei Zhu, Kai Zheng, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 13, pp. 3068-3078
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top